Join to View Full Profile
101 The City Dr SBldg 23Orange, CA 92868
Phone+1 714-456-5153
Dr. Jeyakumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2012 - 2013
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
Lewis Katz School of Medicine at Temple UniversityClass of 2005
Certifications & Licensure
CA State Medical License 2012 - 2027
MA State Medical License 2009 - 2013
IL State Medical License 2005 - 2011
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
- Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
Publications & Presentations
PubMed
- Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicit...Benjamin J Lee, Shawn P Griffin, Jean Doh, Anthony Quach, Yujiao Sun
British Journal of Haematology. 2025-11-12 - 1 citationsA phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia.Ahmed Aribi, Gabriel N Mannis, Yazan F Madanat, Brian A Jonas, Neil Dunavin
Blood Neoplasia. 2025-11-01 - Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion).Ying Zhang, Jack Reid, Deepa Jeyakumar, Kapitolina Semenova, Naqvi Kiran
Cancer Genetics. 2025-11-01
Journal Articles
- Prolymphocytic Transformation of Lymphoplasmacytic Lymphoma; An Extremely Unusual EventKuixing Zhang, Daniel Farrell, Deepa Jeyakumar, Sherif A Rezk, ScienceDirect
Press Mentions
Combo Treatment Sans Chemotherapy Effective for Ph+ ALL ElderlyDecember 12th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
